Rare Diseases & Drug Development
Rare diseases affect small percentage of the population in recent years. Around 80% of rare diseases are genetic in origin. Cambridge Healthtech Institute’s symposium on Drug Discovery for Rare Diseases will bring together leading scientists, clinicians, executives and experts who are involved in finding new drug targets and drug modalities for treating rare disorders.
Epidemiology and Public Health
The study of disease transmission is a crucial module of general wellbeing practice. The control means to bear the cost of the premise to forestall infection and to support the soundness of populaces through the investigation of the event and dispersion of wellbeing related states or occasions, with the investigation of determinants convincing such states
Epidemiology and Cancers:
The study of disease transmission of malignancy is the investigation of the angles influencing malignancy, as an approach to induce likely patterns and causes.
Epidemiology and Sociology
Social the study of disease transmission is an outlet of the study of disease transmission that accentuations especially on the impacts of social-underlying components on conditions of wellbeing.
Epidemiology and Environmental Health
Ecological the study of disease transmission is a division of the study of disease transmission worried about deciding what natural encounters mean for human wellbeing. This field seeks after to see how a few outer danger elements may incline to or guard against sickness, disease, injury, formative irregularities, or passing.